Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001640334-25-000188
Filing Date
2025-02-05
Accepted
2025-02-05 16:08:45
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 lxrp_424b5.htm 424B5 245208
2 lxrp_424b5img1.jpg GRAPHIC 5932
3 lxrp_424b5img3.jpg GRAPHIC 5929
4 lxrp_424b5img4.jpg GRAPHIC 3501
5 lxrp_424b5img5.jpg GRAPHIC 3543
6 lxrp_s3img1.jpg GRAPHIC 4785
7 lxrp_s3img2.jpg GRAPHIC 4785
  Complete submission text file 0001640334-25-000188.txt   286361
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B5 | Act: 33 | File No.: 333-284407 | Film No.: 25593315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)